Prognostic factors in patients treated with taxane-based chemotherapy for recurrent or metastatic endometrial cancer: Proposal for a new prognostic model

PS at diagnosis and relapse within the irradiated area may constitute a valid prognostic model in RMEC patients who receive taxane-based chemotherapy and are able to identify long-term survivors.